News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Norwood Immunology Limited To Seek IPO In US
November 15, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
15/11/2005 13:53:37. Immune therapy developer and Norwood Abbey (ASX:NAL) subsidiary Norwood Immunology (AIM:NIM) has revealed plans to seek an initial public offering (IPO) in the USA, subject to market conditions. More...
Twitter
LinkedIn
Facebook
Email
Print
IPO
Australia
MORE ON THIS TOPIC
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
January 8, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
January 8, 2026
·
5 min read
·
Angela Gabriel
Cancer
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
January 7, 2026
·
2 min read
·
Tristan Manalac
